Stock Analysis
MET (MET) Stock Analysis
MET (MET) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
MET (MET) currently has an AIQ Score of 61/100, indicating a neutral setup. Risk is the strongest factor at 76/100. Quality is the weakest current factor at 43/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
MET at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $100.02 |
| AIQ Score | 61/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $60.75B |
| P/E Ratio (TTM) | 17.98 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $1.10 |
| Revenue (quarter ended 2026-06-30) | $18.88B |
| Dividend Yield (TTM) | 2.46% |
| Beta | 0.76 |
| Volume | 4.03M |
| 52-week range | $67.33-$103.65 |
| RSI 14 | 57.34 |
| 50-Day SMA | $97.55 |
| 200-Day SMA | $85.58 |
| Analyst Price Target | — |
| Next Earnings | — |
MET
Low Priority
Above Peers
Latest quote
- Momentum68
- Value65
- Quality43
- Risk resilience76
- Sentiment—
MET Stock Analysis Summary
MET (MET) currently has an AIQ Score of 61/100, indicating a neutral setup. Risk resilience is the strongest factor at 76/100. Quality is the weakest current factor at 43/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, MET has AIQ Score of 61/100 with Risk resilience base of 76/100 and fading Quality at 43/100. Wait for component alignment before adding exposure.
Risk resilience (76/100) leads while Quality (43/100) lags. This cross-factor spread creates entry timing uncertainty.
Sector · -0.80% stock move · MET classified in its covered industry.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is MET Bullish or Bearish Right Now?
MET currently has a neutral overall setup. Risk Resilience is the strongest factor at 76/100, while Quality is weakest at 43/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 68/100.
- - Risk Resilience is supportive at 76/100.
- - Price is +3.36% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (35 vs 3).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
MET's Technical Analysis Consensus is currently Strong Buy, with 35 buy, 7 neutral, and 3 sell votes. MET's 14-day RSI is 57.34, which places the stock in a constructive momentum range. MET's beta is 0.76, indicating lower market sensitivity than the broad market.
What Changed in MET?
The largest recent change in MET is Momentum moving down by 12.0 points over the available 7-day comparison window. Risk Resilience remains the strongest visible factor.
What Would Change the MET Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
MET Decision Framework
Public evidence layers, setup checks, and risk context for MET.
MET (MET) Stock Analysis
MET has an AIQ Score of 61/100 in a Neutral regime. Risk is strongest at 76/100. Beta is not shown in the current snapshot. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | MET is in a Neutral AIQ regime with score 61/100. |
| Signal Conflict | The primary conflict is that risk leads at 76/100 while quality lags at 43/100. |
| Factor Evidence | Momentum 68/100 · Value 65/100 · Quality 43/100 · Risk 76/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Risk is the strongest factor at 76/100.
Momentum is 68/100 and RSI (14) is 57.3.
MET is in a Neutral regime at 61/100.
Risk factor is 76/100 and annual volatility 23.83%.
Current conflict: risk leads at 76/100 while quality lags at 43/100.
MET Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
MET Fundamentals
MET valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
MET Technical Analysis
MET technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
MET Stock Catalysts
Track MET earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
MET Dividend Analysis
MET dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
MET Financial Data
MET revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
MET Risk Analysis
MET volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
MET Stock News
MET stock news, market tone, recent headlines, and catalyst context.
MET vs Insurance Peers
Current peer cohort: MET · TRV. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| MET Current stock | — | — | — | — | 0.91 | 23.83% | Current |
| TRV Travelers Companies | — | — | — | — | 1.84 | 20.70% | MET vs TRV |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 30, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts3 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching MET
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for MET
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
MET Stock FAQ
What is MET stock price today?
MET's current stock price is $100.02. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is MET bullish or bearish right now?
MET's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is MET's market cap?
MET's market cap is $60.75B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is MET's current P/E ratio?
MET's current P/E ratio is 17.98 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is MET's RSI?
MET's 14-day RSI is 57.34 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is MET above its 50-day and 200-day moving averages?
MET is 3.36% from its 50-day SMA and 17.82% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is MET's next earnings date?
MET's next earnings date is a key event to check before making a decision. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does MET pay a dividend?
MET's dividend yield is 2.46% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.